Clik here to view.
We’ll See What VC
A post on Capital Rants this morning says the Mayfield Fund will be the Ontario Venture Capital Fund’s first investment, that it will be in the range of US$5 – US$7.5 million, and that Mayfield will...
View ArticleClik here to view.
Some Good Clean Tech Synergy: Biotech + Cleantech + Nanotech = $
A story today at GenomeWeb shows a collaboration among biotech, cleantech and high-tech interest groups successfully generating government support: Illinois life-science industry advocates for the...
View ArticleClik here to view.
Canada — and MaRS — Draw Notice on List of Biotechnology Clusters
A report at Genetic Engineering and Biotechnology News, picked up today by FierceBiotech, discusses emerging biotechnology clusters. It’s worth excerpting the whole bit on Canada: Both Toronto and...
View ArticleClik here to view.
Trends Update — Electronic Medical Records: Telus/Microsoft and GE’s Global...
Two Canadian developments on the electronic medical records front: Telus-Microsoft: Telus and Microsoft are developing a patient-centred system that would allow individuals to access and manage their...
View ArticleClik here to view.
New MaRS Innovation CEO Rafi Hofstein Will Lead Products to the Promised Land
Rafi Hofstein has joined MaRS Innovation as its new CEO. He was previously the President and CEO of Hadasit Ltd., the technology transfer company of the Hadassah Medical Organization in Jerusalem, and...
View ArticleClik here to view.
Monday Biotech Deal Review: December 7, 2009
This was a fairly busy week for Canadian biotech deals, including a new brain-y collaboration for MaRS; peace at Patheon; some overallotment and some underallotment; some diversification by Canadian...
View ArticleClik here to view.
Biotech Trends in 2010: Top Three Reasons Why Biotech Companies Should Use...
Tech startups use social media avidly [rabidly?], but biotech companies? Not so much. Biotech companies should be blogging, tweeting and linking in like mad, though. Here’s why: Your customers...
View ArticleClik here to view.
Biotech Bailout: Five Reasons Ontario Needs to Do More to Support Bioscience...
As we head into another budget cycle here in Ontario, there has been a flood of news showing that other jurisdictions are investing heavily in recruitment and stimulus for biotech companies. Each one...
View ArticleClik here to view.
UK Invests £200M In Technology Innovation Centres, Goes with Fraunhofer Model
Prime Minister David Cameron recently made an announcement outlining the UK government’s plan to allocate £200M for the development of a series of technology innovation centres. They will be designed...
View ArticleClik here to view.
Monday Deal Review: April 29, 2013
Welcome to your Monday Biotech Deal Review for April 29, 2013! This week saw Ergoresearch and Amorfix close their previously announced private offerings. Trimel, meanwhile, has raised $40 million from...
View Article
